 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Daniel Matlock and Laura Scherer.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.819 |
|
|
|
-
Scherer LD, McPhetres J, Pennycook G, Kempe A, Allen LA, Knoepke CE, Tate CE, Matlock DD. Who is susceptible to online health misinformation? A test of four psychosocial hypotheses. Health Psychol. 2021 Apr; 40(4):274-284.
Score: 0.765
-
Scherer LD, Matlock DD, Allen LA, Knoepke CE, McIlvennan CK, Fitzgerald MD, Kini V, Tate CE, Lin G, Lum HD. Patient Roadmaps for Chronic Illness: Introducing a New Approach for Fostering Patient-Centered Care. MDM Policy Pract. 2021 Jan-Jun; 6(1):23814683211019947.
Score: 0.196
-
Wallace B, Matlock DD, Scherer A, Fagerlin A, Scherer LD. Life Support Preferences in the Context of COVID-19: Results from a National US Survey. Med Decis Making. 2021 11; 41(8):963-969.
Score: 0.194
-
Ingle MP, Lammons W, Guigli R, Kini V, Matlock DD, Brereton E, Scherer LD. Patient Perspectives on the Benefits and Risks of Percutaneous Coronary Interventions: A Qualitative Study. Patient Prefer Adherence. 2021; 15:721-728.
Score: 0.193
-
Kwon R, Allen LA, Scherer LD, Thompson JS, Abdel-Maksoud MF, McIlvennan CK, Matlock DD. The Effect of Total Cost Information on Consumer Treatment Decisions: An Experimental Survey. Med Decis Making. 2018 07; 38(5):584-592.
Score: 0.159
-
Montembeau SC, Rao BR, Mitchell AR, Speight CD, Allen LA, Halpern SD, Ko YA, Matlock DD, Moore MA, Morris AA, Scherer LD, Ubel P, Dickert NW. Integrating Cost into Shared Decision-Making for Heart Failure with Reduced Ejection Fraction (POCKET-COST-HF): A Trial Providing Out-of-Pocket Costs for Heart Failure Medications during Clinical Encounters. Am Heart J. 2024 03; 269:84-93.
Score: 0.058
-
Vemuru S, Smith S, Colborn K, Huynh V, Leonard L, Bonnell L, Scherer L, Matlock D, Lee C, Kim S, Tevis S. Access to Results of Patient Reported Outcome Surveys Does Not Improve Survey Response Rates. J Surg Res. 2023 03; 283:945-952.
Score: 0.054
-
Rao BR, Speight CD, Allen LA, Halpern SD, Ko YA, Matlock DD, Moore MA, Morris AA, Scherer LD, Thomson MC, Ubel P, Dickert NW. Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure. J Am Heart Assoc. 2022 Jun 20; e023789.
Score: 0.052
-
Thomson MC, Allen LA, Halpern SD, Ko YA, Matlock DD, Mitchell AR, Moore MA, Morris AA, Rao BR, Scherer LD, Speight CD, Ubel PA, Dickert NW. Framing Benefits in Decision Aids: Effects of Varying Contextualizing Statements on Decisions About Sacubitril-Valsartan for Heart Failure. MDM Policy Pract. 2021 Jul-Dec; 6(2):23814683211041623.
Score: 0.050
-
Knoepke CE, Chaussee EL, Matlock DD, Thompson JS, McIlvennan CK, Ambardekar AV, Schaffer EM, Khazanie P, Scherer L, Arnold RM, Allen LA. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial. Med Decis Making. 2022 04; 42(3):404-414.
Score: 0.049
-
Holtrop JS, Scherer LD, Matlock DD, Glasgow RE, Green LA. The Importance of Mental Models in Implementation Science. Front Public Health. 2021; 9:680316.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|